Company Overview and News

 
Decades-long apprenticeship of Li Ka-shing's son is finally over

2018-03-19 thestar.com.my
Whispering in dad's ear: Hong Kong tycoon Li Ka-shing, right, chairman of CK Hutchison Holdings company, chats with his son, co-managing directors Victor Li attend a press conference to announce the company's annual results in Hong Kong, Friday, March 16, 2018. Hong Kong billionaire Li said Friday he is retiring as chairman of his sprawling conglomerate and handing control to his eldest son. - AP
Upvote Downvote

 
Billionaire Li Ka-shing retires

2018-03-17 thestar.com.my
HONG KONG: Li Ka-shing (pic), a wartime refugee who used to sweep factory floors in Hong Kong for a living, retired after a career spanning more than half a century amassing one of Asia’s biggest fortunes from building skyscrapers to selling soap bars.
Upvote Downvote

 
Victor Li finally emerges from the shadow of his Superman father Li Ka-shing

2018-03-16 scmp
Victor, a Stanford University-educated engineer, takes over control of CK Hutchison Holdings and CK Asset Holdings after a decades-long apprenticeship under his illustrious father
Upvote Downvote

 
Li Ka-shing Has Already Left China Behind - WSJ

2018-03-16 wsj
Hong Kong’s Superman is hanging up his cape. 89-year old Li Ka-shing said Friday he will step down as chairman of his flagship conglomerate, CK Hutchison Holdings. With a fortune estimated at $35 billion, Mr. Li should enjoy his retirement.
Upvote Downvote

 
With Li's Exit, Hong Kong's Hungry Tycoons Hail From China - Bloomberg

2018-03-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Hong Kong’s Richest Man Li Ka-shing Retires - Bloomberg

2018-03-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Li Ka-shing retires, ending career of one of Asia’s top tycoons

2018-03-16 thestar.com.my
HONG KONG: Li Ka-shing, a wartime refugee who used to sweep factory floors in Hong Kong for a living, retired after a career spanning more than half a century amassing one of Asia’s biggest fortunes from building skyscrapers to selling soap bars. In announcing his retirement Friday, the 89-year-old chairman of CK Hutchison Holdings Ltd. and CK Asset Holdings Ltd. will stay an adviser to the group. Elder son Victor, 53, will take over a conglomerate that touches the lives of practically everyone in Hong Kong -- the family’s Power Assets Holdings Ltd.
Upvote Downvote

 
Mining M&A tipped to rise in 2018

2018-01-28 australianmining.com.au
Australia’s mid-tier mining sector will potentially see an increase in mergers and acquisitions (M&A) activity in 2018, according to Mergermarket Intelligence.
Upvote Downvote

 
Li's Enticing Sale - Bloomberg

2017-11-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Power Assets announces special dividend, shares gap higher by 9 pc

2017-07-21 scmp
Energy and utility investor Power Assets Group rose 9 per cent to HK$75.15 on Friday morning after reporting a share dividend payment of HK$8.27.
Upvote Downvote

 
Li Ka-shing’s CK Infrastructure sees net income climb 3pc to HK$5.7 bn

2017-07-20 scmp
Two of Li Ka-shing’s cornerstone businesses reported positive progress on Thursday, a week after speculation swirled in the markets that the doyen of Hong Kong business might be starting the process of handing over control of his empire to the family’s next generation.
Upvote Downvote

 
Chorus joins the ASX 200

2017-04-24 nzherald.co.nz
Chorus, whose shares have gained 40 per cent in the past two years, will join the S&P/ASX 200 Index on May 2, bringing to eight the number of New Zealand companies with a primary listing on the NZX that are also on the Australian benchmark index.
Upvote Downvote

 
HK’s Chow Tai Fook wins Aussie approval for Alinta takeover

2017-04-23 themalaymailonline
Australian utilities such as Alinta and Duet have attracted foreign interest because of steady cash flows from their gas and electricity assets. — AFP picSYDNEY, April 23 ― Chow Tai Fook Enterprises Ltd., the Hong Kong conglomerate best known for its jewelry stores, has won Australian regulatory approval to acquire gas and electricity provider Alinta Energy Holdings Ltd.
Upvote Downvote

 
FIRB approves Chow Tai Fook's takeover of Alinta

2017-04-23 theage.com.au
The deal has been approved by the Foreign Investment Review Board and is subject to strict conditions, a spokeswoman for Treasurer Scott Morrison said on Sunday, without elaborating on the details. Mr Morrison decides on approvals for overseas investors on advice from the investment board.
Upvote Downvote

 
FIRB approves Chow Tai Fook's takeover of Alinta

2017-04-23 smh.com.au
The deal has been approved by the Foreign Investment Review Board and is subject to strict conditions, a spokeswoman for Treasurer Scott Morrison said on Sunday, without elaborating on the details. Mr Morrison decides on approvals for overseas investors on advice from the investment board.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...